Company Filing History:
Years Active: 2011-2019
Title: Hisashi Hasegawa: Innovator in Antibody Development
Introduction
Hisashi Hasegawa is a prominent inventor based in Gunma, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of 3 patents to his name, Hasegawa's work has the potential to impact medical treatments significantly.
Latest Patents
Hasegawa's latest patents include the development of an Anti FGF23 antibody and a pharmaceutical composition comprising the same. This invention aims to provide an antibody against FGF23, which can serve as a preventive or therapeutic agent by suppressing the action of FGF23. The antibody or its functional fragment against human FGF23 is produced by hybridoma C10 (Accession No. FERM BP-10772). This innovative approach could lead to new treatments for conditions related to FGF23.
Career Highlights
Throughout his career, Hasegawa has worked with notable companies, including Kyowa Hakko Kirin Co., Limited and Kyowa Kirin Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field of biotechnology.
Collaborations
Hasegawa has collaborated with several talented individuals, including Yuji Yamazaki and Itaru Urakawa. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Hisashi Hasegawa's contributions to antibody development highlight his role as a key innovator in biotechnology. His work has the potential to lead to significant advancements in medical treatments, showcasing the importance of innovation in addressing health challenges.